<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="3513">
  <stage>Registered</stage>
  <submitdate>3/04/2012</submitdate>
  <approvaldate>3/04/2012</approvaldate>
  <nctid>NCT01574144</nctid>
  <trial_identification>
    <studytitle>REducing 30-day ADMIssions in posT-discharge Subjects (READMIT)</studytitle>
    <scientifictitle>Observational Study of Reducing 30-day Admissions in Post-discharge Subjects</scientifictitle>
    <utrn />
    <trialacronym>READMIT-HF</trialacronym>
    <secondaryid>READMIT-HF</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Acute Decompensated Heart Failure</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Coronary heart disease</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - AVIVO PiiX Patch Monitor System

AVIVO PiiX Patch Monitor System - Heart failure patients monitored continuously for 30 days post-discharge.


Treatment: devices: AVIVO PiiX Patch Monitor System
External monitoring for 30 days post-discharge.

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Number of health care utilizations 30 days post-discharge</outcome>
      <timepoint>30 days post-discharge</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Change in impedance 30 days post-discharge - Measures change in weight and tissue impedance throughout the monitoring period post-discharge</outcome>
      <timepoint>30 days post-discharge</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Subject with acute decompensated heart failure

          -  Subject (or legal guardian) willing to give consent for their participation

          -  Subject =18 years of age</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Subject who is expected to receive a heart transplant or a ventricular assist device
             within 6 months

          -  Subject who cannot tolerate placement of external patch monitor on chest in the
             proposed location (ECG Lead II orientation)

          -  Subject with known allergies or hypersensitivities to adhesives or hydrogels

          -  Subject with implantable devices with active minute ventilation sensors.

          -  Subject who will not comply to study protocol requirements. This includes completing
             required data collection, and attending required follow up study visits.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/03/2012</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>70</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/07/2013</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>The Alfred Hospital - Melbourne</hospital>
    <postcode>3004 - Melbourne</postcode>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>California</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Florida</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Minnesota</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>New Jersey</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>New York</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Ohio</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Tennessee</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Medtronic Cardiac Rhythm and Heart Failure</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this observational study is to collect and characterize multiple physiologic
      data from a broad subset of subjects with acute heart failure (HF)

      Changes in physiologic data are expected to correlate with 30-day readmission rates in this
      population</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT01574144</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>READMIT-HF Study Team</name>
      <address>Medtronic</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>